Company intelligence
Curie.Bio
Venture capital designed for drug discovery success
Biotechnology Research
Remote, US
141 employees
Founded 2022
3 public signals
About Curie.Bio
Curie.Bio is a venture capital firm that helps founders discover and develop important new medicines. We do this by investing directly into existing companies, creating focused spinouts, and helping founders build companies from scratch. With $1B under management for seed and Series A rounds, and a 100-person team whose expertise has contributed to more than 40 FDA-approved drugs, we work side by side with founders to reach critical milestones in a highly capital-efficient way.
Verified activity
Signals from Curie.Bio
3 published signals
People
Curie.Bio CXO David Gray has spent twenty years developing CNS drugs across large pharma, biotech, and neurotech.
Reported by Curie.Bio
Presence & Recognition
Curie.Bio congratulated the Ionis team on a significant achievement involving new therapy development for patients and families.
Reported by Aimee Jackson
People
Curie.Bio CXO Timothy Guzi has spent over 30 years making small molecules to make a meaningful difference for patients.
Reported by Curie.Bio